NCT01992614View on ClinicalTrials.gov

A Single Dose Study Of PF-06678552 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy
Interventions
DRUG

PF-06678552 or Placebo

PF-06678552 or placebo will be administered as an extemporaneously prepared solution once in each period.

DRUG

PF-06678552 or Placebo

PF-06678552 or placebo will be administered as an extemporaneously prepared solution once in each period.

DRUG

PF-06678552 or Placebo

PF-06678552 or placebo will be administered as an extemporaneously prepared solution once in each period.

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01992614 - A Single Dose Study Of PF-06678552 In Healthy Subjects | Biotech Hunter | Biotech Hunter